Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline | The BMJ
Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy | Journal of Virology
Defective HIV-1 proviruses produce viral proteins | PNAS
Endothelial dysfunction in HIV + patients under combination... | Download Scientific Diagram
Adding a second step to CAR T-cell therapy may make it effective against HIV | Frederick National Laboratory
Involvement of HIV-1 infection and cART in metabolic dysfunction in... | Download Scientific Diagram
Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir | Scientific Reports
HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women - ScienceDirect
Transient CD4-cell-depletion therapy for HIV/AIDS cure | Chinese Medical Journal
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection | Science Translational Medicine
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells | aidsmap
Persistent immune activation in chronic HIV infection: do any interventions work? (cure research)
Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment | PLOS ONE
cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice | Journal of Virology
Nanomedicine applications towards the cure of HIV - ScienceDirect
Pharmaceutics | Free Full-Text | Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients | HTML
Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury | SpringerLink
Management of HIV/AIDS - Wikipedia
Bone loss associated with HIV infection and initiated by cART. a | The... | Download Scientific Diagram
JCI - TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs
Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice | Journal of Translational Medicine | Full Text
Figure 1 | Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research | SpringerLink
Dynamics of plasma virus levels in a cART-treated HIV + individuals.... | Download Scientific Diagram
Risk of coronary heart disease in patients with HIV infection | Nature Reviews Cardiology
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients | Mucosal Immunology
